Biohaven BHVN Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biohaven's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biohaven's total costs & expenses?
- Biohaven (BHVN) reported total costs & expenses of $130.43M in Q1 2026.
- How has Biohaven's total costs & expenses changed year-over-year?
- Biohaven's total costs & expenses decreased by 41.1% year-over-year, from $221.56M to $130.43M.
- What is the long-term trend for Biohaven's total costs & expenses?
- Over 3 years (2022 to 2025), Biohaven's total costs & expenses has grown at a 9.5% compound annual growth rate (CAGR), from $567.93M to $745.38M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating costs incurred by the company during a reporting period, including research and development, selling, general, and administrative expenses. It serves as a comprehensive measure of the capital required to sustain the company's clinical-stage operations and commercialization efforts. Monitoring this figure is essential for evaluating the company's burn rate and the efficiency of its investment in its drug development pipeline.